Showing results 11 to 18 of 18
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Ocio, EMRichardson, PGRajkumar, SVPalumbo, AMateos, MVOrlowski, RKumar, SUsmani, SRoodman, DNiesvizky, REinsele, HAnderson, KCDimopoulos, MAAvet-Loiseau, HMellqvist, UHTuresson, IMerlini, GSchots, RMcCarthy, PBergsagel, LChim, JCSLahuerta, JJShah, JReiman, AMikhael, JZweegman, SLonial, SComenzo, RChng, WJMoreau, PSonneveld, PLudwig, HDurie, BGSan Miguel, JF | 2014 | 71 | ||
Pharmacokinetics and safety of ixazomib plus lenalidomide–dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study Journal:Journal of Hematology & Oncology | 2015 | 79 | ||
2019 | 10 | |||
Rapid production of clinical-grade SARS-CoV-2 specific T cells Journal:Advances in Cell and Gene Therapy | 2020 | 10 | ||
2018 | 26 | |||
2019 | 27 | |||
2021 | 14 | |||
Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group Journal:American Journal of Hematology | 2012 | 170 |